MedCity News

Wisp members can now order TBD Health’s STI/STD testing kits on Wisp’s website for free delivery.

At the MedCity INVEST conference from May 21-22 at the Ritz Carlton in Chicago, a panel discussion sponsored by Quantum Health will share how employers are addressing value-based care.

The dangers of polypharmacy and its increasingly wide reach across the American population make it imperative that we enhance the accuracy and efficiency of medication reconciliation processes. Yet reversing this trend has historically posed a significant challenge for healthcare. While no one disagrees that polypharmacy needs to be addressed, because of the complexities surrounding polypharmacy—including how to ensure pharmacists have access to the most up-to-date information regarding a patient's medication history, no matter where they receive care—it has often been overlooked as a priority action item for states. Polypharmacy is also a term that describes the problem but is not action oriented. To change medication regimens, clinicians need accurate information and training on how to appropriately deprescribe medications.

Johnson & Johnson’s Proteologix acquisition adds a pipeline of bispecific antibodies, including an experimental treatment for asthma and atopic dermatitis. It’s the latest M&A deal involving molecules addressing TSLP, a key signaling protein involved in inflammation.

Virginia Medicaid beneficiaries now have access to Aeroflow Health's breast pumps and lactation consultants.

While adopting new technology is obviously a big part of healthcare innovation teams' work, there are plenty of worthwhile initiatives that don't involve advanced technologies, pointed out Dan Shoenthal, chief innovation officer at MD Anderson Cancer Center.

In-home hospice care, which gives them ample opportunities to engage with family and friends in the comfort of their own homes, allows providers to give dementia patients the daily contact they deserve.

Amgen's Imdelltra has FDA approval in extensive-stage small cell lung cancer, making it the first bispecific T cell engager approved for treating this type of cancer. Analysts project the new Amgen drug will become a blockbuster seller.

Watershed Health closed a $13.6 million funding round this week. The New Orleans-based company seeks to improve care coordination by connecting providers of all types across the healthcare system.

Uber Health launched Uber Caregiver on Wednesday. The solution allows caregivers to coordinate rides and deliveries on the behalf of the ones they're caring for.